These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical experience with a low-dose contraceptive agent. European studies. Haspels AA. J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703 [Abstract] [Full Text] [Related]
23. Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol. Goldzieher JW. J Reprod Med; 1983 Jan; 28(1 Suppl):53-6. PubMed ID: 6403700 [Abstract] [Full Text] [Related]
24. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history]. Manuilova IA, Dubnitskaia LV, Korsakov SG. Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038 [Abstract] [Full Text] [Related]
25. Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens. Larrañaga A, Sartoretto JN, Winterhalter M, Navas Filho F. Int J Fertil; 1978 Jul; 23(3):193-9. PubMed ID: 40893 [Abstract] [Full Text] [Related]
26. [Correlation between thrombolytic therapy and liver rupture?]. Pansold E, Dzikonski M, Heinrich HG, Schneider J. Z Arztl Fortbild (Jena); 1985 Jul; 79(13):575-6. PubMed ID: 4036189 [No Abstract] [Full Text] [Related]
27. [Morphologic changes in the epithelium of the uterine cervix in long-term administration of the 19-norsteroid-containing oral hormonal contraceptives Non-Ovlon and gravistat]. Geissler U. Zentralbl Gynakol; 1988 Jul; 110(5):267-76. PubMed ID: 2453979 [Abstract] [Full Text] [Related]
32. Pulmonary embolism in a woman taking oral contraceptives and valdecoxib. Westgate EJ, Fitzgerald GA. PLoS Med; 2005 Jul; 2(7):e197. PubMed ID: 16013893 [Abstract] [Full Text] [Related]
33. Fertility control with norgestrel and ethynil estradiol. Report on continuing studies. Rice-Wray E, Cervantes A, Garcilazo J, Valenzuela P. J Reprod Med; 1972 Aug; 9(2):45-9. PubMed ID: 5050402 [No Abstract] [Full Text] [Related]
34. [Risks of postcoital contraception using a d-norgestrel-ethinyl estradiol combination]. Welti H, Nguyen Duy N, Zufferey MM. Ther Umsch; 1986 May; 43(5):438-40. PubMed ID: 3726780 [No Abstract] [Full Text] [Related]
36. [Jaundice after ovulation inhibiting steroids]. Fritsch H, Kaess H. Med Klin; 1969 May 09; 64(19):894-7. PubMed ID: 5772231 [No Abstract] [Full Text] [Related]
37. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Jick SS, Kaye JA, Russmann S, Jick H. Contraception; 2006 Mar 09; 73(3):223-8. PubMed ID: 16472560 [Abstract] [Full Text] [Related]
38. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO. Poindexter AN, Burkman R, Fisher AC, LaGuardia KD. Int J Fertil Womens Med; 2003 Mar 09; 48(4):163-72. PubMed ID: 13677549 [Abstract] [Full Text] [Related]
39. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies. Woutersz TB. J Reprod Med; 1975 Sep 09; 15(3):87-92. PubMed ID: 1214254 [Abstract] [Full Text] [Related]